These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 19107609

  • 1. The Kras2 oncogene and mouse lung carcinogenesis.
    Lee GH.
    Med Mol Morphol; 2008 Dec; 41(4):199-203. PubMed ID: 19107609
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.
    Yanagitani N, Kohno T, Sunaga N, Kunitoh H, Tamura T, Tsuchiya S, Saito R, Yokota J.
    Carcinogenesis; 2002 Jul; 23(7):1177-83. PubMed ID: 12117776
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mouse pulmonary adenoma susceptibility 1 locus is an expression QTL modulating Kras-4A.
    Dassano A, Colombo F, Trincucci G, Frullanti E, Galvan A, Pettinicchio A, De Cecco L, Borrego A, Martinez Ibañez OC, Dragani TA, Manenti G.
    PLoS Genet; 2014 Apr; 10(4):e1004307. PubMed ID: 24743582
    [Abstract] [Full Text] [Related]

  • 9. Expression quantitative trait analysis reveals fine germline transcript regulation in mouse lung tumors.
    Cotroneo CE, Dassano A, Colombo F, Pettinicchio A, Lecis D, Dugo M, De Cecco L, Dragani TA, Manenti G.
    Cancer Lett; 2016 Jun 01; 375(2):221-230. PubMed ID: 26966001
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.
    Manenti G, Trincucci G, Pettinicchio A, Amendola E, Scarfò M, Dragani TA.
    Oncogene; 2008 Sep 25; 27(43):5753-8. PubMed ID: 18560355
    [Abstract] [Full Text] [Related]

  • 13. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene.
    Lin L, Festing MF, Devereux TR, Crist KA, Christiansen SC, Wang Y, Yang A, Svenson K, Paigen B, Malkinson AM, You M.
    Exp Lung Res; 1998 Sep 25; 24(4):481-97. PubMed ID: 9659579
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genetic mapping of cancer susceptibility/resistance loci in the mouse.
    Manenti G, De Gregorio L, Gariboldi M, Falvella FS, Zanesi N, Pierotti MA, Dragani TA.
    Recent Results Cancer Res; 1998 Sep 25; 154():292-7. PubMed ID: 10027009
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of vinyl carbamate-induced lung tumors and Kras2 mutations by the garlic derivative diallyl sulfone.
    Hernandez LG, Forkert PG.
    Mutat Res; 2009 Mar 09; 662(1-2):16-21. PubMed ID: 19101575
    [Abstract] [Full Text] [Related]

  • 20. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
    Sweet-Cordero A, Mukherjee S, Subramanian A, You H, Roix JJ, Ladd-Acosta C, Mesirov J, Golub TR, Jacks T.
    Nat Genet; 2005 Jan 09; 37(1):48-55. PubMed ID: 15608639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.